Worried about the Zika virus? You’re not alone. Puerto Rico is struggling to get contraceptives to women who are at risk of becoming infected by the mosquito-borne virus. Both the Centers for Disease Control and the World Health Organization are raising awareness of potential risks for people attending the Olympic Games in Rio de Janeiro, Brazil, this summer.
In the midst of all these concerns, there’s some good news: On Monday, Inovio Pharmaceuticals (NASDAQ:INO) announced a decision by the U.S. Food and Drug Administration (FDA) that marks an important step in potentially preventing Zika infection -- and positions Inovio as the leader in the race to develop a Zika vaccine.
